A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Nathan De Boeck und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbiology, VIB-KU Leuven, 3001 Leuven, Belgium. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Amikacin, Anti-Bacterial Agents, Clarithromycin. Die Arbeit nennt 63 Literaturangaben. Gefördert von: VLAIO, MCIN, FWO.
Abstract (Originalsprache)
Aims
We aimed to investigate the molecular mechanisms underlying the survival of Mycobacterium abscessus when faced with antibiotic combination therapy. By conducting evolution experiments and whole-genome sequencing (WGS), we sought to identify genetic variants associated with stress response mechanisms, with a particular focus on drug survival and resistance. Methods and results We conducted evolution experiments on M. abscessus, exposing the bacteria to a combination therapy of amikacin and rifabutin. Genetic mutations associated with increased antibiotic survival and altered susceptibility were subsequently identified by WGS. We focused on mutations that contribute to stress response mechanisms and tolerance. Of particular interest was a novel frameshift mutation in MAB_3509c, a gene of unknown function within the upstream open reading frame of whiB7. A MAB_3509c knockout mutant was constructed, and expression of downstream drug resistance genes was assessed by RT-qPCR. Mutation of MAB_3509c results in increased RNA levels of whiB7 and downstream stress response genes such as eis2, which is responsible for aminoglycoside resistance.
Conclusion
Our findings demonstrate the importance of whiB7 in the adaptive stress response in M. abscessus. Moreover, our results highlight the complexity of M. abscessus adapting to drug stress and underscore the need for further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Microbiology, VIB-KU Leuven, 3001 Leuven, Belgium.
- Centre of Microbial and Plant Genetics, KU Leuven, 3001 Leuven, Belgium.
- Infectious Diseases Therapeutic Area, LLC, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.
- Grupo de Genética de Micobacterias, Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza IIS-Aragón, 50009 Zaragoza, Spain.
- CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Jan Michiels
Förderung
- VLAIO
- MCIN
- FWO
- KU
- AEI
Zitieren
APA
De Boeck, N., Villellas, C., Crespo-Yuste, E., Gonzalo-Asensio, J., Buckley, P. T., Thys, K., Vuong, C., Lounis, N., Verstraeten, N., & Michiels, J. (2024). A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae286
Vancouver
De Boeck N, Villellas C, Crespo-Yuste E, Gonzalo-Asensio J, Buckley PT, Thys K, et al. A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae286
BibTeX
@article{DeBoeck2024,
author = {De Boeck, Nathan and Villellas, Cristina and Crespo-Yuste, Estefanía and Gonzalo-Asensio, Jesús and Buckley, Peter T and Thys, Kim and Vuong, Cuong and Lounis, Nacer and Verstraeten, Natalie and Michiels, Jan},
title = {A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessus},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae286}
}
EUVIMED